Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
about
Implications of Genetic and Epigenetic Alterations of CDKN2A (p16(INK4a)) in CancerCombating the epigenome: epigenetic drugs against non-Hodgkin's lymphomaDeciphering the Epigenetic Code in Embryonic and Dental Pulp Stem CellsMicroRNA-152 regulates DNA methyltransferase 1 and is involved in the development and lactation of mammary glands in dairy cowsTAp73 and ΔNp73 have opposing roles in 5-aza-2'-deoxycytidine-induced apoptosis in breast cancer cells.Inhibiting DNA Methylation by 5-Aza-2'-deoxycytidine ameliorates atherosclerosis through suppressing macrophage inflammation.Identification of small molecule modulators of gene transcription with anticancer activity.Aptamer Displacement Screen for Flaviviral RNA Methyltransferase Inhibitors.Reversal of microRNA-150 silencing disadvantages crizotinib-resistant NPM-ALK(+) cell growthDecreased Sp1 Expression Mediates Downregulation of SHIP2 in Gastric Cancer Cells.Crosstalk between microRNA and DNA Methylation Offers Potential Biomarkers and Targeted Therapies in ALK-Positive LymphomasMAL and TMEM220 are novel DNA methylation markers in human gastric cancer.Curcumin Reactivates Silenced Tumor Suppressor Gene RARβ by Reducing DNA Methylation.The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells.p16 promoter hypermethylation is associated with increased risk of nasopharyngeal carcinoma.Treponema denticola increases MMP-2 expression and activation in the periodontium via reversible DNA and histone modifications.New avenues for targeted therapies and biomarkers in anaplastic large cell lymphoma.An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit from epigenetic therapy.
P2860
Q26739706-A58C3FCF-5242-407E-8EAC-8CD77B54956DQ26851166-C60C8AB5-7761-4120-9944-46BA3C3D51D7Q28080288-7D171BA8-F1F3-48F9-BAB1-04D6A5F7BD39Q33837871-99D5390C-BE3E-4EDF-AC71-2B3D95A3CA6DQ34092090-96733E9A-5955-40A0-8ECC-1C3A6340EEFDQ34551679-59B3FEDF-6C0B-4061-A2DC-4CD50532638FQ34576203-E52CBF51-E55D-4279-8A42-580B38A249ACQ35162542-6B05C5AE-82CE-4C65-91E8-67E544667757Q36106068-4F59D305-6D71-4A24-AC91-81341854CBFBQ37631723-35A33C8A-841C-4BB3-97FD-545929E8FEE4Q38644718-BF4FE6D1-EDD4-4DAE-A32D-32DA9243CAA5Q38762957-47AEDB06-8371-47E4-84FE-FBFF8B1429C4Q38874057-840C72B4-422B-497C-9857-B0DE57E6DE9AQ40996500-69CE3304-8293-4C32-82FC-C80419AA14C3Q42921451-FFCEA071-BEA6-4819-A2DA-D7DE6E33806EQ46021184-471EB77E-DD0D-4559-A227-88F1C433A416Q52801642-FE391790-4CF3-40D3-A056-A3CB6CD208FEQ55106924-9669F9C3-8F7E-48BC-BFD6-6ADCFA57ED8A
P2860
Antineoplastic activity of the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine in anaplastic large cell lymphoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antineoplastic activity of the ...... naplastic large cell lymphoma.
@ast
Antineoplastic activity of the ...... naplastic large cell lymphoma.
@en
type
label
Antineoplastic activity of the ...... naplastic large cell lymphoma.
@ast
Antineoplastic activity of the ...... naplastic large cell lymphoma.
@en
prefLabel
Antineoplastic activity of the ...... naplastic large cell lymphoma.
@ast
Antineoplastic activity of the ...... naplastic large cell lymphoma.
@en
P2093
P2860
P921
P1433
P1476
Antineoplastic activity of the ...... anaplastic large cell lymphoma
@en
P2093
Aleksandra Klisaroska
Ana-Iris Schiefer
Irene Steiner
Karoline Kollmann
Melanie R Hassler
Veronika Sexl
P2860
P304
P356
10.1016/J.BIOCHI.2012.05.029
P5008
P577
2012-06-09T00:00:00Z